Cytokinetics, Incorporated (CYTK)
NASDAQ: CYTK · Real-Time Price · USD
56.19
-2.43 (-4.15%)
Nov 12, 2024, 4:00 PM EST - Market closed
Cytokinetics Employees
Cytokinetics had 423 employees as of December 31, 2023. The number of employees increased by 14 or 3.42% compared to the previous year.
Employees
423
Change (1Y)
14
Growth (1Y)
3.42%
Revenue / Employee
$7,610
Profits / Employee
-$1,362,652
Market Cap
6.63B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 423 | 14 | 3.42% |
Dec 31, 2022 | 409 | 156 | 61.66% |
Dec 31, 2021 | 253 | 69 | 37.50% |
Dec 31, 2020 | 184 | 28 | 17.95% |
Dec 31, 2019 | 156 | 26 | 20.00% |
Dec 31, 2018 | 130 | -7 | -5.11% |
Dec 31, 2017 | 137 | 10 | 7.87% |
Dec 31, 2016 | 127 | 27 | 27.00% |
Dec 31, 2015 | 100 | 8 | 8.70% |
Dec 31, 2014 | 92 | 7 | 8.24% |
Dec 31, 2013 | 85 | 15 | 21.43% |
Dec 31, 2012 | 70 | -9 | -11.39% |
Dec 31, 2011 | 79 | -26 | -24.76% |
Dec 31, 2010 | 105 | -6 | -5.41% |
Dec 31, 2009 | 111 | 1 | 0.91% |
Dec 31, 2008 | 110 | -51 | -31.68% |
Dec 31, 2007 | 161 | 13 | 8.78% |
Dec 31, 2006 | 148 | -2 | -1.33% |
Dec 31, 2005 | 150 | -20 | -11.76% |
Dec 31, 2004 | 170 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Bausch + Lomb | 13,300 |
Elanco Animal Health | 9,800 |
Jazz Pharmaceuticals | 2,800 |
Legend Biotech | 1,826 |
Ionis Pharmaceuticals | 927 |
Ascendis Pharma | 879 |
Lantheus Holdings | 834 |
Blueprint Medicines | 655 |
CYTK News
- 1 day ago - Cytokinetics Announces Initiation of Phase 1 Clinical Study of CK-4015089 - GlobeNewsWire
- 6 days ago - Cytokinetics, Incorporated (CYTK) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 days ago - Cytokinetics Reports Third Quarter 2024 Financial Results - GlobeNewsWire
- 8 days ago - Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 20 days ago - Cytokinetics to Announce Third Quarter Results on November 6, 2024 - GlobeNewsWire
- 27 days ago - Cytokinetics Highlights Progress in Cardiac Myosin Modulation Programs and Global Commercial Launch Readiness at Investor & Analyst Day - GlobeNewsWire
- 6 weeks ago - Cytokinetics Presents Additional Data From SEQUOIA-HCM at the HFSA Annual Scientific Meeting - GlobeNewsWire
- 6 weeks ago - Cytokinetics Presents Additional Data from SEQUOIA-HCM at the HCMS Scientific Sessions - GlobeNewsWire